111 related articles for article (PubMed ID: 7696397)
1. Xenotransplantation of canine tumors into severe combined immunodeficient (SCID) mice.
Sugimoto T; Maruo K; Imaeda Y; Suzuki K; Shirota K; Ejima H; Endo S; Nomura T
J Vet Med Sci; 1994 Dec; 56(6):1087-91. PubMed ID: 7696397
[TBL] [Abstract][Full Text] [Related]
2. Growth and metastasis of two canine mast cell tumors in SCID mice.
Maruo K; Sugimoto T; Suzuki K; Shirota K; Yamane Y; Nomura T
J Vet Med Sci; 1996 Jun; 58(6):567-9. PubMed ID: 8811629
[TBL] [Abstract][Full Text] [Related]
3. Xenotransplantation and high tumorigenicity of feline tumors in SCID mice.
Maruo K; Sugimoto T; Suzuki K; Shirota K; Ejima H; Nomura T
J Vet Med Sci; 1995 Oct; 57(5):967-9. PubMed ID: 8593316
[TBL] [Abstract][Full Text] [Related]
4. Xenografts of primary human prostatic carcinoma.
Pretlow TG; Wolman SR; Micale MA; Pelley RJ; Kursh ED; Resnick MI; Bodner DR; Jacobberger JW; Delmoro CM; Giaconia JM
J Natl Cancer Inst; 1993 Mar; 85(5):394-8. PubMed ID: 8433392
[TBL] [Abstract][Full Text] [Related]
5. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a canine xenograft model of inflammatory mammary carcinoma.
Camacho L; Peña L; González Gil A; Cáceres S; Díez L; Illera JC
Res Vet Sci; 2013 Dec; 95(3):1068-75. PubMed ID: 23972378
[TBL] [Abstract][Full Text] [Related]
7. Canine Thyroid Cancer: Molecular Characterization and Cell Line Growth in Nude Mice.
Hassan BB; Altstadt LA; Dirksen WP; Elshafae SM; Rosol TJ
Vet Pathol; 2020 Mar; 57(2):227-240. PubMed ID: 32081094
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic neoplasms arising from basal cellcarcinoma xenotransplants into SCID-beige mice.
Carlson JA; Combates NJ; Stenn KS; Prouty SM
J Cutan Pathol; 2002 May; 29(5):268-78. PubMed ID: 12100626
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
10. Growth and metastasis of fresh human benign and malignant tumors in the head and neck regions transplanted into scid mice.
Inohara H; Matsunaga T; Nomura T
Carcinogenesis; 1992 May; 13(5):845-9. PubMed ID: 1586997
[TBL] [Abstract][Full Text] [Related]
11. X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.
Wood M; Udagawa T; Hida Y; D'Amato RJ
Cancer Res; 2005 Jul; 65(13):5690-5. PubMed ID: 15994943
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of canine malignant lymphomas in the nude and SCID mouse.
Baron T; Doré JF
In Vivo; 1992; 6(1):77-9. PubMed ID: 1627746
[TBL] [Abstract][Full Text] [Related]
13. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
Visonneau S; Cesano A; Torosian MH; Miller EJ; Santoli D
Am J Pathol; 1998 May; 152(5):1299-311. PubMed ID: 9588898
[TBL] [Abstract][Full Text] [Related]
14. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
[TBL] [Abstract][Full Text] [Related]
16. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
17. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects.
Hudson WA; Li Q; Le C; Kersey JH
Leukemia; 1998 Dec; 12(12):2029-33. PubMed ID: 9844934
[TBL] [Abstract][Full Text] [Related]
18. Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice.
Huang P; Allam A; Taghian A; Freeman J; Duffy M; Suit HD
J Neurosurg; 1995 Aug; 83(2):308-15. PubMed ID: 7616277
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma.
Camacho L; Peña L; Gil AG; Martín-Ruiz A; Dunner S; Illera JC
Vet Pathol; 2014 Jul; 51(4):737-48. PubMed ID: 24048323
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficient mouse models of lymphoid tumors.
Imada K
Int J Hematol; 2003 May; 77(4):336-41. PubMed ID: 12774920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
